Progress Indicator Animation

Summary
To assemble the Troygenics, we designed many composite parts for different sections of our project. Our best composite part is the completed Application Plasmid which codes for an endocytosis ligand and GFP. This composite part, BBa_K2926093, is one of the plasmids to assemble our functional Troygenics and a customizable framework to use the Troygenic for many different applications. Based on this framework, only one cloning step is required to change the target organism of the Troygenic or change the function of the Troygenic. With the help of this composite part, severall iGEM Teams from all over the world are able to fight eukaryotic pathogenes, make silenced gene clusters accessible or transform eukaryotes. Thus, our Troygenic offers the possibility to transform the world into a better place.

Best composite part

Our best composite part is the part BBa_K2926093, Trp_sfGFP_MatA_mCherry_M13K07 gene VIII_M13K07 gene III. This part is one version of a correctly built Application Plasmid and thus the most important building block for functional Troygenics

Theory

BBa_K2926093 consits of the basic parts BBa_K2926007 (ITR before basic insert), BBa_K2926091 (TRP1), BBa_K517000 (GALL promoter), BBa_K1321337 (sfGFP), BBa_K2926005 (TPs1 yeast terminator), BBa_ K2926013 (ITR after basic insert), BBa_K314110 (f1 origin), BBa_K2926054 (Fusion protein mating factor alpha, mCherry and pVIII), and BBa_ K2926013BBa_K2926026 (truncated pIII).

The basic insert is cloned into the backbone (pSB1C3). This basic insert contains inverted terminal repeats (ITRs), the selection marker TRP1, a promoter, a gene of interest and a terminator. The inverted terminal repeats of both flankes of the insert enable the genome integration in Saccharomyces cerevisiae and the TRP1 facilitates homologous recombination in S. cerevisiae. S. cerevisiae has got a point mutation in its tryptophan producing gene, whereby the production of the essential amino acid tryptophan is not possible. When the Troygenic has been taken up by the organism and had inserted its DNA into the genome, the defect TRP gene is repaired by homologous recombination using the plasmid DNA as template. Integrated in the yeast tryptophane functions as a selective marker as yeast with inserted TRP can produce tryptophan and survives in minimal medium without added tryptophan. When the basic insert is integrated into the genome of S. cerevisiae, the expression of the sfGFP as our gene of interest can be induced by addition of galactose. The transcription is stopped by the TPs1 yeast terminator.

Basic insert containing ITRs, TRP1, GALL promoter, sfGFP and TPs1 yeast terminator

One of the main components of our Application plasmid is the basic part BBa_K2926093, an f1 origin of replication. The f1 origin of replication is an important feature of the Application Plasmid because it enables replication of Application Plasmid in the expression organism as well as packing the Application Plasmid into the Troygenics and therefore allowing the cells to produce single stranded DNA.

Another important basic part of the finished Application Plasmid is the fusion protein consisting of the endocytosis ligand mating factor α (Matα), the fluorescence marker mCherry and gene VIII from the M13K07 helperphage. The gene VIII enables that the endocytosis ligand can be located through mCherry outside on the coat of our Troygenics, which is mainly built out of the major coat proteins pVIII. Thereby, Matα is available for S. cerevisiae and the uptake of the Troygenics by endocytosis is possible. Furthermore, mCherry is located outside of the Troygenics on its coat making the Troygenics easy to detect by fluorescence spectroscopy.

The Fusion protein consisting of Matα, mCherry and pVIII

The last part component of BBa_K2926093 is the truncated pIII from the M13K07 helperphage. It was constructed by removing the wild-type protein’s N-terminus. Therefore we removed the N1 and N2 regions as well as the linkers. To combat possible safety concerns the gene III is placed on the Application Plasmid in regard that the Assembly Plasmid can not be used to assemble Troygenics o its own without the pIII.

Co-transformed with BBa_K2926028, the Assembly Plasmid, BBa_K2926093 is able to assemble functional Troygenics, which can be taken up by S. cerevisiae through endocytosis and can be transformed into yeast with sfGFP as an optical control.

Determining the optimal endocytosis ligands

The functionality of our Troygenics depends on a specific and efficient uptake into the target organism. To overcome the barrier of the cell membrane, we used the same approach as many non-enveloped viruses do. A common way into their target is to exploit endocytotic pathways of the host cells (Thorley et al. 2010). Apart from the relatively unspecific ways of macropinocytosis many viruses bind their target cells through host-specific proteins presented on their surface and induce endocytosis into the host cell. Those proteins are often ligands for cell specific surface receptors or transporters (Cossart and Helenius 2014).

Cloning detectable fusion proteins

To gain access to our model organism S. cerevisiae, we examined three different ligands. The first one is the mating factor alpha (Mat), which specifically binds the mating pheromone receptor Ste2 that is taken up into the cell upon binding to the pheromone (Bardwell 2004). The second ligand is the extracellular cysteine-rich domain of the S. cerevisiae membrane receptor Opy2 (Opy). Opy2 binds extracellularly to the receptor Hkr1 in the osmoregulatory pathway (Tatebayashi et al. 2015). And finally, the N-terminal domain of the surface protein Flo11 (Flo) was investigated. This domain is able to bind to other Flo11-proteins on the yeasts surface (Douglas et al. 2007; Goossens and Willaert 2012; Karunanithi et al. 2010).
While specific endocytosis of the Mat-Ste2-complex is described in literature, the uptake of Opy- or Flo-bound Troygenics would rely on constitutive endocytosis which is an important mechanism to maintain membrane-homeostasis in every living organism (Besterman and Low 1983; Samaj et al. 2004).
Since there are no known pheromones for A. niger, we use a different, virus-inspired approach. Many viruses use target cell specific transporters to be actively internalized by their host (Olah et al. 1994; Fujisawa and Masuda 2007; Tailor et al. 1999). Knowing this, we fused three prolines interspaced by a glycine-linker to mCherry (Pro_mCherry) to take advantage of the Aspergillus-specific proline transporter PrnB suggested by Prof. Diallinas from the Department of Biology of the National and Kapodistrian University of Athens. The fusion-protein will block the proline-transporter which triggers endocytosis of the blocked PrnB.

For closer investigation of our selected ligands, we fused them to mCherry, a red fluorescent protein. This enables us to detect the fusion-proteins Mat_mCherry(BBa_K2926049), Flo_mCherry (BBa_K2926050), Opy_mCherry (BBa_K2926051) and Pro_mCherry (BBa_K2926068) inside and outside the cell via fluorescence measurement (Fig. 4).

**mCherry-ligand-fusion-proteins.**
The fusion of the fluorescent protein mCherry to the cell specific ligand allows detection of the protein of interest inside and outside the cell.

Protein purification

First, the marker protein mCherry (BBa_J06504) was cloned into the expression- and purification-vector pTXB1. To express the desired fusion-proteins the coding sequence of the specific ligands, containing a short C-terminal glycine-serine-linker was successfully cloned into the pTXB1-mCherry plasmid upstream of mCherry. This resulted in four different pTXB1-constructs coding for the fusion-proteins Mat_mCherry(BBa_K2926049), Flo_mCherry (BBa_K2926050), Opy_mCherry (BBa_K2926051) and Pro_mCherry (BBa_K2926068), each time fused to the intein-chitin binding domain, thus ready for protein purification. Those fusion-proteins were expressed in E. coli ER2566. The expression was easily detectable by the red color of the culture (Fig. 5 and 6).

**Expression culture of the fusion-proteins.**
Opy_mCherry, Mat_mCherry, Flo_mCherry and Pro_mCherry (from left to right) in pTXB1 expressed in *E. coli* ER2566. Expression cultures were cultivated at 37 °C in LB containing 100 mg ampicillin per L, to an OD of 0.6. Expression was induced by addition of IPTG to a final concentration of 0.4 mM. After additional 30 minutes at 37 °C, cultures were transferred to 17 °C and protein was expressed over night.

The expression cultures showed different intensities of red which indicated varying levels of expression or a different fluorescence intensity of the expressed proteins.

**Harvested expression culture of the fusion-proteins.**
Expression cultures were harvested via centrifugation for 20 min at 4 °C and 4 000 rpm.

After cultivation we compared two different protocols for cell lysis. Lysis via Ribolyzer resulted in a much lower yield than lysis via French Press (Fig. 7).

**Ribolyzer (left) and French Press (right).**
Harvested cells were lysed using Zirconia metal beads (1 mm) in a Ribolyzer at 8 000 rpm for 15 s. Lysis via French Press was performed two times at 16 000 psi with a flow rate of around 1 mL per minute. The lysate was cleared by centrifugation at 4 °C for 1 h and 4 500 rpm.

Purification of the fusion-proteins from the cell-lysate was performed using the IMPACT-Kit from NEB. The protein of interest was C-terminally fused to an intein tag and a chitin-binding domain. The resulting protein was loaded onto a chitin column (Fig. 8) and washed with a buffer with a high salt concentration.

**Purification columns loaded with the fusion-proteins.**
Cleared lysate was loaded onto a chitin column and washed with a buffer with high salt concentration. After washing the protein split off the chitin column, it was washed in PBS and concentrated.

To cleave the protein of interest from the column, it was incubated with DTT for 20-24 hours. After purification the different fusion proteins were analyzed on a SDS-PAGE to determine the purity as well as the correct molecular weight of the fusion-proteins (Fig. 9).

**SDS-PAGEs of the purification process.**
The purification process and the purified proteins were analyzed via SDS-PAGE. *E. coli* lysate of the expression culture, flow-through- and wash-fraction of the column purification as well as the purified protein were denatured by heating the samples to 98 °C for 10 min in SDS-PAGE loading buffer containing DTT and loaded on an polyacrylamide-gel (12 %). The proteins were separated through electrophoresis (25 mA). Protein bands in the purified protein samples likely originating from the target protein are marked in red.

The SDS-PAGE and a subsequent Bradford assay showed that we were able to purify Mat_mCherry with a molecular weight of 28.7 kDa and a yield of 2.35 mg, Opy_mCherry with a molecular weight of 31 kDa and a yield of 1.48 mg, Flo_mCherry with a molecular weight of 48.3 kDa and a yield of 40.9 µg and Pro_mCherry with a molecular weight of 27.7 kDa and a yield of 67.9 µg. To verify that the correct proteins were purified the marked bands were excised from the SDS-PAGE, washed, digested with trypsine and analyzed in a MALDI-ToF MS (Fig. 10).

**Mass spectrum of the fusion proteins Mat_mCherry (1), Opy_mCherry (2), Flo_mCherry (3) and Pro_mCherry (4) after tryptic digestion compared to the theoretical mass spectrum.**
Excised bands from the SDS-PAGEs of Mat_mCherry, Opy_mCherry, Flo_mCherry and Pro_mCherry were washed, digested over night with trypsine and co-crystallized with a α-Cyano-4-hydoxycinnamic acid-matrix on a MALDI target. The mass spectrum was recorded in a MALDI-ToF MS from Bruker Daltronics and data was evaluated using the software BioTools (Bruker). The upper panel for each sample shows the comparison between the obtained and the theoretical mass spectrum. The lower panels show individual matches (red) between the detected peptides and the amino acid sequence of the fusion-proteins.

The generated mass spectra and mass lists were evaluated using the software BioTools (Bruker). To compare the experimentally determined data to the theoretical protein sequence we performed an in silico trypsine-digestion of the expected protein sequence and compared the generated mass spectrum and mass list to the measured ones. We were able to match the obtained spectra for all four investigated fusion-proteins to the theoretically determined spectra.

Protein characterization

A very important property of the fusion-proteins is the ability to fluoresce unaffected by the fusion at the N-terminus. To verify this, we measured the fluorescence- and absorbance spectra of all four fusion-proteins (Fig. 11).

**Fluorescence- and absorbance-spectra of the fusion proteins.**
Emission- (dashed lines) and absorption-spectra (solid lines) of Mat_mCherry (dark red), Opy_mCherry (dark purple), Flo_mCherry (purple) and Pro_mCherry (blue) were measured (λ_Ex=570 nm, λ_Em=600 nm to 800 nm) using the TECAN infinite M200 and normalized to their maximum.

All four fluorescence spectra look very similar. The absorbance spectra of all four fusion proteins are matching each other as well. Overall, the fluorescence- and absorbance-spectra of the fusion-proteins are very similar to the ones measured for mCherry (Fig. 12).

**Fluorescence- and absorbance-spectra of mCherry and Mat_mCherry as an example for a fusion-protein.**
Emission- (dashed lines) and absorbance-spectra (solid lines) of Mat_mCherry (dark red) and mCherry (grey) were measured (λ_Ex=570 nm, λ_Em=600 nm to 800 nm) using the TECAN infinite M200 and normalized to their maximum.

To further characterize the fluorescence properties of the purified proteins, we diluted the proteins from 0.01 µM to 0.5 µM and compared the fluorescence intensity to the one of mCherry standardized to the fluorescence of 0.5 µM Texas Red (Fig. 13)

**Fluorescence intensity of a dilution series of the fusion-proteins.**
Fluorescence intensity of the dilution series of the fusion-proteins Mat_mCherry (dark red), Opy_mCherry (dark purple), Flo_mCherry (purple), Pro_mCherry (blue) and mCherry (grey) were measured (λ_Ex=570 nm, λ_Em=610 nm, gain calculated from 2.5 µM Texas Red) using the TECAN infinite M200 and normalized to the fluorescence intensity of 0.5 µM Texas Red at the same wavelength.

As a result, we observed that Pro_mCherry showed the highest fluorescence intensity followed by Flo_mCherry, Mat_mCherry and Opy_mCherry. Compared to mCherry, the fluorescence intensity of the fusion-proteins has been decreased (Fig. 13). The fluorescence intensity of 1 µmol Flo mCherry equals the fluorescence of 0.49 µmol Texas Red, the fluorescence intensity of 1 µmol Mat_mCherry equals the intensity of 0.47 µmol Texas Red, the fluorescence intensity of 1 µmol Opy_mCherry equals the intensity of 0.41 µmol Texas Red and the fluorescence intensity of Pro_mCherry equals the fluorescence intensity of 0.54 µmol Texas Red. Normalizing the fluorescence intensity to a reference dye like Texas red enables the comparability of data, measured in different experimental setups and labs. After normalizing the data to a fixed value, the determination using a comparable relative fluorescence unit (RFU) is possible.

Endocytosis assays

The function of the ligands in the final Troygenics is to facilitate their binding and uptake by endocytosis. To demonstrate this functionality, we used the ligand-mCherry fusion-proteins in different endocytosis assays.

Fluorescence in the supernatant

With the purified fusion-proteins Mat_mCherry, Opy_mCherry, Flo_mCherry and Pro_mCherry, as well as mCherry, we performed an endocytosis-assay (Fig. 14). S. cerevisiae was incubated for one hour with 1 µM fusion-protein. Every 15 minutes a sample was taken, cells were pelleted by centrifugation and the fluorescence intensity in the supernatant was determined using a plate reader (Fig. 15).

**Schematic overwiev of the endocytosis assay**
Target cells are incubated with the fusion-protein. Over the time the cells specifically take up the proteins from the media. This results in a measurable decrease of fluorescence in the medium.

Mat_mCherry, Opy_mCherry and mCherry are taken up by *S. cerevisiae*
*S. cerevisiae* was incubated in SD medium (30 °C, 180 rpm, OD aro 0.4, dark) over 1 h with 1 µM mCherry (grey), Mat_mCherry (dark red), Opy_mCherry (dark purple) and Flo_mCherry (purple). Every 15 minutes, a sample was taken, the cells were pelleted by centrifugation, and the remaining fluorescence in the supernatant was measured using the TECAN infinite M200 (λ_Ex=570 nm, λ_Em=610 nm, gain calculated from 2.5 µM Texas Red). The results were normalized to the fluorescence intensity at t=0 and the fluorescence intensity of the negative control without cells.

The results show that the fluorescence intensity in the supernatant of the samples with Mat_mCherry, Opy_mCherry and mCherry decreases over the time. This indicates that Opy_mCherry, Mat_mCherry and even mCherry alone seem to interact with and might be taken up by S. cerevisiae. The specific ligands Mat and Opy seem to enhance endocytosis as shown by the faster decrease of fluorescence in the medium. In contrast, the fluorescence intensity of Flo_mCherry in the supernatant did not decrease over the time which led us to the conclusion that the fusion-protein is not taken up by the cell.

The same assay described above for S. cerevisiae was carried out for A. niger as a model organism for filamentous fungi to verify the uptake of Pro_mCherry into the cells. Additionally, to investigate the specificity of the tested ligands, A. niger was also incubated with the S. cerevisiae-specific Mat_mCherry (Fig. 16).

**The proline-fused mCherry is selectively taken up by the target organism *A. niger*.**
*A. niger* was incubated in SD media (30 °C, 180 rpm, dark) over 1 h with 0.5 µM mCherry (grey), Mat_mCherry (dark red) and Pro_mCherry (blue). After 60 minutes, a sample was taken and the remaining fluorescence in the supernatant was measured using the TECAN infinite M200 (λ_Ex=570 nm, λ_Em=610 nm, gain calculated from 2.5 µM Texas Red). The results were normalized to the fluorescence intensity at t=0 and the fluorescence intensity of the negative control without cells.

Due to the lower growth rate of A. niger compared to S. cerevisiae, only one sample after 60 minutes was taken. The results show no change in fluorescene in the supernatant after 60 min for mCherry or the S. cerevisiae-specific Mat_mCherry. This indicates that neither mCherry nor Mat_mCherry were taken up by A. niger. In contrast the assumed ligand of the Aspergillus-specific proline transporter Pro_mCherry was able to enter A. niger successfully as seen by the 20 % decreased fluorescence readout in the supernatant.
In conclusion our results show that it is possible to find organism-specific ligands that selectively enhance endocytosis into the targeted cell while not binding or entering cells from other organisms.

Fluorescence microscopy

In addition to the described endocytosis assays, we showed that our ligands specifically enhance endocytosis in their target cells, using fluorescence microscopy (Fig. 17). In detail we show the uptake of the fusion-proteins by S. cerevisiae (Fig. 18). Using fluorescence microscopy we can verify that the fusion-proteins are truly entering the target cell and are not just attaching to the cell wall or degraded by secreted proteases.

**Fluorescence microscope.**
To verify the specific uptake of our fusion-proteins into the target cell, we investigated fusion-protein-treated target cells under the fluorescence microscope LSM700 (Zeiss).

**Fluorescence microscopy of *S. cerevisiae* after incubation with different fusion-proteins shows their specific uptake into the cells.**
*S. cerevisiae* (0.35 OD) was resuspended in YPD (60 µL) and incubated (30 min, 30 °C, 450 rpm, dark) with mCherry (upper left), Mat_mCherry (upper right), Opy_mCherry (lower left) or Flo_mCherry (lower right). After washing with PBS, the cells were visualized using a fluorescence microscope (Fig. 17) (LSM 700 (Zeiss), magnification: 100 x, filters: Texas Red [λ_Ex=555 nm, λ_Em=570 nm to 800 nm], transmitted light).

In the fluorescence microscopy Mat_mCherry (upper right) and Opy_mCherry (lower left) were detectable within the cells. Mat_mCherry was taken up with a slightly higher efficiency than Opy_mCherry (data not shown). In contrast Flo_mCherry (lower right) seemed to form precipitates outside the cells while the negative control mCherry without any fusion-partner was not taken up by S. cerevisiae.

In conclusion, we showed by an endocytosis assay as well as fluorescence microscopy that our S. cerevisiae- ligands mating factor alpha and the cysteine-rich domain of Opy2 as well as the A. niger ligand, a short proline-peptide, were able to enhance endocytosis in the targeted cells. We also showed that Mat_mCherry is target-specific for S. cerevisiae and is not taken up into A. niger cells. As such, we were able to proof our initial concept of using organism-specific ligands to introduce proteins and ultimately our Troygenics specifically into the targeted organism as the specific uptake into the targeted organisms is our first mechanism to ensure specificity for our system in potential application.

First, we did a Sanger sequencing with the fully cloned part.

To demonstrate the functionality of BBa_K2926093 we co-transformed it with BBa_K2926028 in E. coli ER2566 as the expressing organism. After cultivation and growing on selective agar, we cultivated single picked colonies in SOC medium. We purified the Troygenics following the protocol NEB recommends for phage purification.

With our purified Troygenics we performed Bradford assay and determined a protein concentration of 44,14 ng/µL.

We also tested the fluorescence of the Troygenics assembled with the proteins of BBa_K2926093 with a microtiter plate reader. We could detect a fluorescence intensity similar to mCherry. The peakshift (Fig. 19) occurs due to the fusion of mCherry to further proteins of the Troygenics, which leads to a altered folding of mCherry and thus results in a slight variation of emission spectrum.

Fluorescence spectrum of Troygenics assembled with the BBa_K2926093 coded proteins compared to mCherry fluorescence spectrum of purified protein

As our Troygenics built with BBa_K2926093 as Application Plasmid are supposed to aim at Saccharomyces cerevisiae, we infected a yeast culture with the Troygenics. Therefore we took 1.5 mL over-night yeast culture and 50 µL of purified Troygenics and inoculated the mixture for 30 minutes at 30 °C. Afterwards we plated it on Agarplates with yeast minimal medium without Tryptophan but with galactose.

When the yeast has grown, we did a colony PCR on the cultures. This colony PCR came to a positive result, as you can see in the following gel picture.

Colony PCR on S. cerevisiae treated with Troygenics built with BBa_K2926093

Applications

After demonstrating the functionality of all components in isolation (see results), we finally assembled complete Troygenics. Firstly, S. cerevisiae-specific Troygenics that present mating factor alpha on their coat, produce sfGFP, and carry TRP1, a marker gene for tryptophane-auxotrophic yeast strains, were produced. We purified the Troygenics after production and successfully performed initial transformation experiments.
Next steps could be the optimization of transformation conditions of our Troygenics to improve the transformation rate. Finding the ideal concentration of Troygenics is crucial for efficient transformation of the target cells. Additionally, further evaluation of the specificity of our Troygenics is necessary. A comparison of the transformation efficiency in the target cell and a closely related non-target cell could reveal the transformation specificity.

Applications in agriculture, food and nutrition

Since we demonstrated the functionality of our Troygenics in the non-pathogenic model organisms S. cerevisiae and A. niger, our Troygenics can be adapted to fight several plant pathogenic fungi. Numerous experts have pointed out that pathogens like Phytophtera infestans, Puccinia graminis and Fusarium oxysporum pose a huge threat to the world’s food supply and considered our Troygenics an innovative solution.

Applications in environmental issues

Apart from fighting plant pathogenic fungi, Troygenics could emerge as a simplification of challenging task in the lab e.g. the transformation of fungi and other eukaryotes. There is a variety of possible applications ranging from creating new production strains in the industry to fighting eukaryotic pathogens in the environment. Not only do plant pathogenic fungi pose a dangerous threat, but so do those infecting animals and even humans. Bat- or toad-infecting fungi that endanger the entire species are already in existence. The loss of these species would have a detrimental impact on entire eco systems. To deploy our Troygenics against those threats, only small modifications are necessary. A target specific ligand has to be fused to the major coat protein pVIII and short target specific guideRNAs need to be exchanged in the CeDIS.

Medical applications

Fungi are not the only eukaryotic pathogens. Trypanosoma, which cause the African sleeping sickness and often result in the patients' death (WHO), are another challenge that could eventually be tackled by Troygenics. Since our Troygenics would specifically fight the Trypanosoma while having no effect on the human cells, they show great advantages to conventional treatments. Usually, Trypanosoma are treated with chemicals. Those chemicals have to cross the blood-brain-barrier, like Trypanosoma do, too. Unfortunately the common treatments can show severe side-effects that result in serious brain-damage (WHO). Troygenics offer a potential resource for the development of less invasive treatment.

Our Troygenics constitute a universal platform for overcoming various imminent problems.

Further composite parts

We built a similar composite part than BBa_K2926093 with Opy2p instead of mating factor α (BBa_K2926212). The Bradford assay confirmed a protein concentration of 60.16 ng/µL.

Furthermore, we planned to integrate our CeDIS as a basic insert instead of the sfGFP. This would be more composite parts functioning as our Application Plasmid. Because of the limited time we could not clone the CeDIS with Lsh, Lwa or Lbu into the plasmid with Matα or Opy2p.

If we would modify the gRNAs of the CeDIS or the ligand for endocytosis, we could create lots of more Application Plasmid versions, which supports our aim of a customizable platform system.

All composite parts

List of all composit parts
Part	Basic parts	Description	Designer	Length
BBa_K2926228	BBa_K2926023, BBa_K2926024, BBa_K2926025	M13K07_genes_II-VIII_Terminator_genes_III-IV	Nefeli Chanoutsi, Astrid Többer	4906 bp
BBa_K2926029	BBa_K314110, BBa_K2926026, BBa_K2926027	f1_ori_mCherry-M13K07-pVIII-fusion_pIII	Nefeli Chanoutsi, Astrid Többer	2050 bp
BBa_K2926260	BBa_J23104, BBa_K2926048	BBa_J23104_mCherry-His	Isabel Conze	770 bp
BBa_K2926261	BBa_J23108, BBa_K2926048	BBa_J23108_mCherry-His	Isabel Conze	770 bp
BBa_K2926262	BBa_J23110, BBa_K2926048	BBa_J23110_mCherry-His	Isabel Conze	770 bp
BBa_K2926263	BBa_J23114, BBa_K2926048	BBa_J23114_mCherry-His	Isabel Conze	770 bp
BBa_K2926264	BBa_M13108, BBa_K2926048	P8-Prom_mCherry-His	Isabel Conze	782 bp
BBa_K2926269	BBa_K2926007, BBa_K2926003, BBa_K2323000, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926006, BBa_K2926013	Basic insert coding for Cas13a(Lwa) for expression in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	4821 bp
BBa_K2926270	BBa_K2926007, BBa_K2926003, BBa_K2926001, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926006, BBa_K2926013	Basic insert coding for Cas13a(Lbu) for expression in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	4785 bp
BBa_K2926271	BBa_K2926007, BBa_K2926003, BBa_K2926000, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926006, BBa_K2926013	Basic insert coding for Cas13a(Lsh) for expression in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	5473 bp
BBa_K2926272	BBa_K2926007, BBa_K2926003, BBa_K1321337, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_J06504, BBa_K2926006, BBa_K2926013	Basic insert to express sfGRP and mCherry in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	2745 bp
BBa_K2926273	BBa_K2926007, BBa_K2926003, BBa_K1321337, BBa_K2926005, BBa_K2926013	Basic insert to express sfGFP in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	1480 bp
BBa_K2926283	BBa_K2926007, BBa_K2926003, BBa_K2323000, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926009, BBa_K2926006, BBa_K2926013	Basic insert to express Cas13a (Lwa) and a guideRNA array in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	5383 bp
BBa_K2926284	BBa_K2926007, BBa_K2926003, BBa_K2926001, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926009, BBa_K2926006, BBa_K2926013	Basic insert to express Cas13a (Lbu) and a guideRNA array in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	5228 bp
BBa_K2926285	BBa_K2926007, BBa_K2926003, BBa_K2926000, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926009, BBa_K2926006, BBa_K2926013	Basic insert to express Cas13a (Lsh) and a guideRNA array in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	5916 bp
BBa_K2926286	BBa_K2926007, BBa_K2926003, BBa_K2323000, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926008, BBa_K2926006, BBa_K2926013	Basic insert to express Cas13a (Lwa) and a short guideRNA array in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	5135 bp
BBa_K2926287	BBa_K2926007, BBa_K2926003, BBa_K2926001, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926008, BBa_K2926006, BBa_K2926013	Basic insert to express Cas13a (Lbu) and a short guideRNA array in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	4980 bp
BBa_K2926288	BBa_K2926007, BBa_K2926003, BBa_K2926000, BBa_K2926005, BBa_I732006, BBa_K2926004, BBa_K2926008, BBa_K2926006, BBa_K2926013	Basic insert to express Cas13a (Lsh) and a short guideRNA array in S. cerevisiae	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	5668 bp
BBa_K2926093	BBa_K2926007, BBa_K2926091, BBa_K517000, BBa_K1321337, BBa_K2926005, BBa_K2926013, BBa_K314110, BBa_K2926054, BBa_K2926026	Trp_sfGFP_MatA_mCherry_M13K07 gene VIII_M13K07 gene III	Nefeli Chanoutsi, Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Astrid Többer, Katharina Wolff	3983 bp
BBa_K2926222	BBa_K2926007, BBa_K2926091, BBa_K517000, BBa_K1321337, BBa_K2926005, BBa_K2926013, BBa_K314110, BBa_K2926056, BBa_K2926026	Trp_sfGFP_Opy2p_mCherry_M13K07 gene VIII_M13K07 gene III	Nefeli Chanoutsi, Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Astrid Többer, Katharina Wolff	4066 bp
BBa_K2926304	BBa_K2916015, BBa_K2926011, BBa_K2926105	Cas13a guideRNA cluster (Aspergillus) with promoter and terminator	Isabel Conze, Johanna Opgenoorth, Ina Schmitt, Katharina Wolff	2179 bp

Team:Bielefeld-CeBiTec/Composite Part